Comparative Efficacy and Safety of Empagliflozin with Other Antidiabetic Drugs for the Third Line Treatment of Type 2 Diabetes Mellitus
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- November 2014
has subject area
- 1117 Public Health and Health Services (FoR)
- 1402 Applied Economics (FoR)
- Health Policy & Services (Science Metrix)
published in
- Value in Health Journal